SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001144204-13-003080
Filing Date
2013-01-18
Accepted
2013-01-18 16:01:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRER14A v332527_prer14a.htm PRER14A 682137
  Complete submission text file 0001144204-13-003080.txt   683137
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: PRER14A | Act: 34 | File No.: 000-25169 | Film No.: 13537632
SIC: 2834 Pharmaceutical Preparations